Frailty-stratified randomised controlled bayesian adaptive trial of bortezomib versus lenalidomide in transplant-ineligible myeloma - the FRAIL-M study (MRFF LSCD Grant Administered by Monash) (2019-2023)
Experts
Professor
Ruth Hubbard
Masonic Chair of Geriatric Medicine
Frazer Institute
Faculty of Health, Medicine and Behavioural Sciences
